Protocol Page


	Study ID (Protocol Number)
	CA184-162


	STUDY LOCATIONS*
	Memorial Sloan Kettering Cancer Center New York, NY 10021 Recruiting	Nyu Clinical Cancer Center New York, NY 10016 Recruiting
	Mount Sinai Medical Center Miami Beach, FL 33140 Recruiting	The University Of Texas Md Anderson Cancer Center Houston, TX 77030 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
	STUDY OVERVIEW
	The purpose of the study is to compare the efficacy of Ipilimumab and standard of care immediately after first-line chemotherapy in the treatment of unresectable or metastatic gastric and gastro-esophageal cancer

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.